University Hospital, Lille: clinical-trial pipeline

University Hospital, Lille is the sponsor of 630 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 158 are not yet finished and 2 were first posted in the last 90 days. Source: Arcadium Data, data as of .

Open trials158
Phase 2/3 and 331
Countries16
New in 90 days2

Trials by phase

PhaseTrials
Not applicable538
Phase 230
Phase 325
Phase 414
Phase 1/28
Phase 17
Phase 2/36
Early phase 12

Trials by status

StatusTrials
Completed371
Recruiting118
Terminated75
Withdrawn or not authorised25
Not yet recruiting22
Active, not recruiting18
Unknown1

Condition areas

AreaTrials
Neurology78
Oncology75
Infectious disease and vaccines64
Cardiovascular56
Gastroenterology and liver54
Rare and genetic diseases54
Metabolic and endocrine (diabetes, obesity)53
Immunology and rheumatology46
Respiratory45
Women's health and obstetrics40
Psychiatry and mental health36
Dermatology24

Countries

CountryTrials
France594
Belgium9
Germany2
Martinique2
Netherlands2
Austria1
Canada1
Czechia1
Spain1
United Kingdom1
Guadeloupe1
Greece1
Japan1
Luxembourg1
Portugal1

Latest changes

DayChangeTrial
2026-09-09New trial postedObservational Study of IgE-Mediated Leguminous Allergies in a Pediatric Population
2026-08-27New trial postedCharacterization of Peri-Hemorrhagic Cerebral Edema Using Synthetic Sodium Imaging With 7…

Open trials

The 25 most recently changed open trials.

Registry idTitlePhaseStatusCountries
NCT06448572EXL01 in Combination With Nivolumab for Advanced NSCLC Refractory to Immunotherapy.Phase 1/2RecruitingFrance
NCT05572229Study of Teclistamab in Combination in Elderly Patients With Multiple MyelomaPhase 2Active, not recruitingFrance
NCT04400539The IMmunotherapy Pleural 5-ALA PDTPhase 2RecruitingFrance
NCT03713203PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Paget's Disease of the Vulva (EMPV).Not applicableRecruitingFrance
NCT06649227Study Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19Phase 1RecruitingFrance
NCT03243175Avoiding Anticoagulation After IntraCerebral HaemorrhagePhase 3RecruitingFrance
NCT04570085Effect of CAFfeine on Cognition in Alzheimer's DiseasePhase 3RecruitingFrance
NCT03243019Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic MalformationsPhase 2RecruitingFrance
NCT06110403Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathless…Phase 1/2RecruitingFrance
NCT06956482PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic HepatitisPhase 3RecruitingFrance
NCT05534399Antibiotic Strategy and Asymptomatic Bacteriuria in the Context of Intra-vesical Botulinum Toxin A Injections.Not applicableNot yet recruitingFrance
NCT07275515DIROXIMEL FUMARATE TO REDUCE PERIHAEMATOMAL OEDEMA IN INTRACEREBRAL HAEMORRHAGE: DOUBLE BLIND RANDOMIZED CLIN…Phase 2RecruitingFrance
NCT04522193Dumping Syndrome and Esophageal AtresiaNot applicableRecruitingFrance
NCT07273656Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and F…Phase 3Not yet recruiting
NCT05116072Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperati…Phase 1/2RecruitingFrance
NCT03517072Determinants of the Long-Term Success of Bariatric SurgeryNot applicableRecruitingFrance
NCT07055191TOETVA Technique Compared With Anterior Cervical Thyroidectomy (AC) in Terms of Efficacy and SafetyNot applicableRecruitingFrance
NCT04573673Transcutaneous Tibial Neuro-stimulation to Improve Voiding Dysfunction in Multiple Sclerosis.Not applicableRecruitingFrance
NCT04058782Impact of Peripheral Vascular Stiffness Assessment on Risk Prediction in Patients With Myocardial InfarctionNot applicableActive, not recruitingFrance
NCT07770386Performance of Carbon Dioxide (CO2)-Derived Parameters in Predicting Low Cardiac Output SyndromeNot applicableRecruitingFrance
NCT04334031Deployment o the Multidisciplinary Prospective Cohort ImminentNot applicableRecruitingFrance
NCT04330118Origin and Function of Eosinophilic Polynuclear During DRESS SyndromeNot applicableRecruitingFrance
NCT05699005Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMOPhase 1RecruitingFrance
NCT04179695Evaluation of a New Communication Aid Tool to Favor Global Patient Centered CareNot applicableRecruitingFrance
NCT04365998BUBOLight®, a New Phototherapy Device for the Treatment of the Newborn's JaundiceNot applicableRecruitingFrance

All sponsors: clinical-trial pipeline by sponsor.

Track a sponsor's pipeline

The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.

Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.

Cite as: Arcadium Data, "University Hospital, Lille clinical trials: 158 open, 31 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/university-hospital-lille/, data as of 2026-10-25.